NEW YORK, April 27, 2016 /PRNewswire/ -- Postpartum hemorrhage (PPH) can be defined as blood loss in excess of 500 mL after vaginal delivery or more than 1,000 mL after cesarean delivery. If this amount of blood loss occurs within 24 hours of delivery, it is categorized as early or primary PPH. If such blood loss occurs after 24 hours of delivery, it is categorized as late or secondary PPH. This study provides market analysis for various medical devices that are used for the treatment of postpartum hemorrhage. The stakeholders of this market report comprise established medical device manufacturers, distributors, and new players who wish to enter the global postpartum hemorrhage treatment devices market.
This study provides a comprehensive analysis of the global postpartum hemorrhage treatment devices market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the PPH treatment devices market in terms of current and future market size along with growth rate.
The market overview section provides thorough information on the trends in the usage of medical devices used for the treatment of PPH, such as drivers, restraints, and growth opportunities that presently regulate the dynamics of the overall market. Competitive analysis tools such as Porter's Five Forces analysis and market attractiveness analysis have also been incorporated in this report to provide analysis about the level of competition within the postpartum hemorrhage treatment devices market. Furthermore, a section analyzing the regulatory framework and major events provides a bird's-eye view on the major and upcoming events occurring in the global postpartum hemorrhage treatment devices market that could impact growth. Competitive intelligence tools such as heat map analysis have also been included in the market overview section of the report to deliver a broad spectrum of the overall scenario in the market at global level. Heat map analysis thus provided in this study is in context with major product manufacturers and distributors operating in the market; this would help new players to understand the key business models and geographical presence and identify the specific product lines of existing companies to establish a strong presence in the PPH treatment devices market.
The global postpartum hemorrhage treatment devices market has been segmented based on various products used across various geographies. The postpartum hemorrhage treatment devices market has been categorized into major products used for providing therapeutic treatment measures such as non-pneumatic anti-shock garment (NASG), the Uniject prefilled injection system, and uterine balloon tamponade. The uterine balloon tamponade segment has been further segmented into Foley catheters, condom catheters, and others (e.g. Bakri, Rusch, etc.). The market size for the period from 2013 to 2023 has been provided for each of the product categories mentioned above in terms of USD million. Along with the market size that was projected considering 2014 as the base year and 2013 as the historical year, the CAGR (%) of each market segment for the forecast period from 2015 to 2023 has also been provided.
Geographically, the PPH treatment devices market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. North America has been further segmented into the U.S. and Canada; Europe into Germany, the U.K. and Rest of Europe; Asia Pacific into China, Japan, and Rest of Asia Pacific. The market revenue of PPH treatment devices for each geographical region for 2013 and 2023 along with forecast from 2015 to 2023 in respective regions in terms of USD million, has been explained in the geography section of the report.
This market study concludes with profiles of key players in the global postpartum hemorrhage treatment devices market. The report summarizes the companies in terms of overview, financial overview, product portfolio, business strategies, and recent developments. Key organizations profiled in this study include Cook Medical, Inc., Teleflex Incorporated, C. R. Bard, Inc., 3rd Stone Design, Inc., Bactiguard AB, Program for Appropriate Technology in Health (PATH), Utah Medical Products, Inc., and ZOEX NIASG.
The global postpartum hemorrhage treatment devices market is segmented into the following categories:
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products
Non-pneumatic Anti-shock Garment (NASG)
Uniject Prefilled Injection System
Uterine Balloon Tamponade
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography
Rest of Europe
Rest of Asia Pacific
Latin America (LATAM)
Middle East & North Africa (MENA)
Rest of the World
Read the full report: http://www.reportlinker.com/p03289837-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
Intl: +1 339-368-6001